Clovis Oncology, Inc. was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $50.12 –$60.97 in the past one-month time frame, witnessed a sharp increase yesterday.

The move came after the company reported financial results for the fourth quarter and Year-End 2017, and provided an update on the company’s clinical development programs and regulatory and commercial outlook for 2018.

The company has seen a flat track record when it comes to estimate revisions over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Clovis Oncology, Inc. Price

Clovis Oncology, Inc. Price | Clovis Oncology, Inc. Quote

Clovis Oncology currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the Medical sector is Bioverativ Inc. , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CLVS going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>